Vimarsana
Biggest News Aggregation in the World

Page 21 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Singhal Today - Breaking & Trending Today

Insider Selling: Biogen Inc. (NASDAQ:BIIB) Insider Sells $100,329.55 in Stock - Vimarsana News

Insider Selling: Biogen Inc. (NASDAQ:BIIB) Insider Sells $100,329.55 in Stock

Biogen Inc. (NASDAQ:BIIB – Get Free Report) insider Priya Singhal sold 419 shares of Biogen stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $239.45, for a total transaction of $100,329.55. Following the transaction, the insider now owns 4,516 shares in the company, valued at […]

Biogen (NASDAQ:BIIB) Issues FY24 Earnings Guidance - Vimarsana News

Biogen (NASDAQ:BIIB) Issues FY24 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $15.00-$16.00 for the period, compared to the consensus earnings per share estimate of $15.81. Biogen also updated its FY 2024 guidance to 15.000-16.000 EPS. Biogen Stock Down 1.6 % Shares […]

Biogen (NASDAQ:BIIB) Releases FY 2024 Earnings Guidance - Vimarsana News

Biogen (NASDAQ:BIIB) Releases FY 2024 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 15.000-16.000 for the period, compared to the consensus estimate of 15.650. The company issued revenue guidance of -. Biogen also updated its FY24 guidance to $15.00-$16.00 EPS. Biogen Stock Down 1.9 % […]

Biogen (NASDAQ:BIIB) Upgraded at StockNews.com - Vimarsana News

Biogen (NASDAQ:BIIB) Upgraded at StockNews.com

StockNews.com upgraded shares of Biogen (NASDAQ:BIIB – Free Report) from a hold rating to a buy rating in a research note released on Monday. A number of other research firms also recently weighed in on BIIB. Wedbush raised their price target on shares of Biogen from $239.00 to $245.00 and gave the stock a neutral […]

Biogen (NASDAQ:BIIB) Reaches New 52-Week Low Following Analyst Downgrade - Vimarsana News

Biogen (NASDAQ:BIIB) Reaches New 52-Week Low Following Analyst Downgrade

Biogen Inc. (NASDAQ:BIIB – Get Free Report) hit a new 52-week low on Thursday after Robert W. Baird lowered their price target on the stock from $333.00 to $316.00. Robert W. Baird currently has an outperform rating on the stock. Biogen traded as low as $220.56 and last traded at $222.80, with a volume of […]